2020, Volume 22, Issue 3
Strategic Study of CAE >> 2020, Volume 22, Issue 3 doi: 10.15302/J-SSCAE-2020.03.017
Phototherapy of Neurodegenerative Diseases: Mechanism, Application, and Prospect
1. Biomedical Engineering Department, Peking University, Beijing 100191, China;
2. Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China;
3. College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518061, Guangdong, China;
4. MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, China
Next Previous
Abstract
Neurodegenerative diseases are a heterogeneous group of irreversible illnesses caused by the progressive loss of neuronal structure or function, leading to cognitive and movement disorders, without safe and effective treatments. Exploring the application potential of non-invasive physical therapy for neurodegenerative diseases is of great significance for disease remission and effective control. Phototherapy is a method that uses the interaction of light and tissue to treat diseases and promote the rehabilitation of the body through photochemical or photophysical reactions, with precise and minimally invasive features. Low-light therapy is a type of non-invasive phototherapy that is used in promoting wound healing, pain relief, inflammation regression, and tissue regeneration. Clinical studies have also confirmed that low-light therapy can effectively improve the pathological symptoms of patients with neurodegenerative diseases. Thus, as a non-invasive physical therapy, low-light therapy provides a promising new direction for the relief and effective control of neurodegenerative diseases. This article summarizes the research progress of low-light therapy for neurodegenerative diseases and prospects its application in conjunction with the development of optoelectronic technology. It is suggested that the mechanism and dose effect relationship of low light should be clarified, new low-light treatment technology should be developed, and the clinical verification system and evaluation index should be improved, so as to benefit patients and serve the society as soon as possible.
Keywords
phototherapy ; low-light therapy ; non-invasive physical therapy ; neurodegenerative diseases
Figures
Fig. 1
Fig. 2
References
[ 1 ] Yun S H, Kwok S J J. Light in diagnosis, therapy and surgery [J]. Nature Biomedical Engineering, 2017, 1(1): 1–16. link1
[ 2 ] Hong N. Photobiomodulation as a treatment for neurodegenerative disorders: Current and future trends [J]. Biomedical Engineering Letters, 2019, 9(3): 359–366.
[ 3 ] Hamblin M R. Shining light on the head: Photobiomodulation for brain disorders [J]. BBA Clinical, 2016, 6: 113–124. link1
[ 4 ] Hamblin M R. Mechanisms and mitochondrial redox signaling in photobiomodulation [J]. Photochemistry and Photobiology, 2018, 94(2): 199–212. link1
[ 5 ] Meng C, He Z, Xing D. Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: Implications for Alzheimer’s disease [J]. Journal of Neuroscience, 2013, 33(33): 13505–13517. link1
[ 6 ] Zhang H, Wu S, Xing D. Inhibition of Aβ25–35-induced cell apoptosis by Low-power-laser-irradiation (LPLI) through promoting Akt-dependent YAP cytoplasmic translocation [J]. Cellular Signalling, 2012, 24(1): 224–32. link1
[ 7 ] Liang J, Liu L, Xing D. Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway [J]. Free Radical Biology and Medicine, 2012, 53(7): 1459–1467. link1
[ 8 ] Song S, Zhou F, Chen W R. Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: Implications for neurodegenerative diseases [J]. Journal of Neuroinflammation, 2012, 9(1): 219. link1
[ 9 ] Birks J S. Cholinesterase inhibitors for Alzheimer’s disease [J]. Cochrane database of systematic reviews, 2006, 1(1): CD005593. link1
[10] Kishi T, Matsunaga S, Iwata N. The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: A meta-analysis [J]. Neuropsychiatric Disease and Treatment, 2017, 13: 1909. link1
[11] Taboada L D, Yu J, El-Amouri S, et al. Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice [J]. Journal of Alzheimer’s Disease, 2011, 23(3): 521–535. link1
[12] Tao L, Wang X, Zhou Q, et al. Near infra-red light treatment of Alzheimer’s disease [C]. Bellingham: International Society for Optics and Photonics, 2019. link1
[13] Purushothuman S, Johnstone D M, Nandasena C, et al. Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex–evidence from two transgenic mouse models [J]. Alzheimer’s Research & Therapy, 2014, 6(1): 2. link1
[14] Farfara D, Tuby H, Trudler D, et al. Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer’s disease [J]. Journal of Molecular Neuroscience, 2015, 55(2): 430–436. link1
[15] Comerota M M, Krishnan B, Taglialatela G. Near infrared light decreases synaptic vulnerability to amyloid beta oligomers [J]. Scientific Reports, 2017, 7(1): 1–11. link1
[16] Lu Y, Wang R, Dong Y, et al. Low-level laser therapy for beta amyloid toxicity in rat hippocampus [J]. Neurobiology of Aging, 2017, 49: 165–182. link1
[17] Grillo S L, Duggett N A, Ennaceur A, et al. Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer’s disease mouse model, TASTPM [J]. Journal of Photochemistry and Photobiology B: Biology, 2013, 123: 13–22. link1
[18] Zinchenko E, Navolokin N, Shirokov A, et al. Pilot study of transcranial photobiomodulation of lymphatic clearance of betaamyloid from the mouse brain: Breakthrough strategies for nonpharmacologic therapy of Alzheimer’s disease [J]. Biomedical Optics Express, 2019, 10(8): 4003–4017.
[19] Zhang Y, Wang F, Luo X, et al. Cognitive improvement by photic stimulation in a mouse model of Alzheimer’s disease[J]. Current Alzheimer Research, 2015, 12(9): 860–869. link1
[20] Iaccarino H F, Singer A C, Martorell A J, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia [J]. Nature, 2016, 540(7632): 230–235. link1
[21] Adaikkan C, Middleton S J, Marco A, et al. Gamma entrainment binds higher-order brain regions and offers neuroprotection [J]. Neuron, 2019, 102(5): 929–943. link1
[22] Martorell A J, Paulson A L, Suk H-J, et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition [J]. Cell, 2019, 177(2): 256–271, e22. link1
[23] Jin L Y, Shi B X, Zhou C. The effect on serum amyloid β protein of patients with mild cognitive impairment after semiconductor laser therapy [J]. Journal of Qingdao University (Medical Sciences), 2000, 36(3): 175–176. Chinese. link1
[24] Arakelyan H S. Treatment of Alzheimer’s disease with a combination of laser, magnetic field and chromo light (colour) therapies: A double-blind controlled trial based on a review and overview of the etiological pathophysiology of Alzheimer’s disease [J]. Laser Therapy, 2005, 14(1): 19–28. link1
[25] Maksimovich I V. Dementia and cognitive impairment reduction after laser transcatheter treatment of Alzheimer’s disease [J]. World Journal of Neuroscience, 2015, 5(3): 189. link1
[26] Lim L. The potential of treating Alzheimer’s disease with intranasal light therapy [C]. Toronto: MedicLights Research Inc., 2013. link1
[27] Berman M H, Halper J P, Nichols T W, et al. Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition [J]. Journal of Neurology and Neuroscience, 2017, 8(1): 176. link1
[28] Saltmarche A E, Naeser M A, Ho K F, et al. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report [J]. Photomedicine and Laser Surgery, 2017, 35(8): 432–441. link1
[29] Shaw V E, Peoples C, Spana S, et al. Patterns of cell activity in the subthalamic region associated with the neuroprotective action of near-infrared light treatment in MPTP-treated mice [J]. Parkinson’s Disease, 2012, 2012 : 296875. link1
[30] Moro C, Torres N, Massri N E, et al. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: Evidence from two mouse strains [J]. BMC Neuroscience, 2013, 14(1): 40. link1
[31] Massri N E, Johnstone D M, Peoples C L, et al. The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice [J]. International Journal of Neuroscience, 2016, 126(1): 76–87. link1
[32] Reinhart F, Massri N E, Chabrol C, et al. Intracranial application of near-infrared light in a hemi-parkinsonian rat model: The impact on behavior and cell survival [J]. Journal of Neurosurgery, 2016, 124(6): 1829–1841. link1
[33] Purushothuman S, Nandasena C, Johnstone D M, et al. The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism [J]. Brain Research, 2013, 1535: 61–70. link1
[34] Reinhart F, Massri N E, Darlot F, et al. 810 nm near-infrared light offers neuroprotection and improves locomotor activity in MPTPtreated mice [J]. Neuroscience Research, 2015, 92: 86–90. link1
[35] Moro C, Massri N E, Torres N, et al. Photobiomodulation inside the brain: A novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice [J]. Journal of Neurosurgery, 2014, 120(3): 670–683. link1
[36] Darlot F, Moro C, Massri N E, et al. Near-infrared light is neuroprotective in a monkey model of Parkinson disease [J]. Annals of Neurology, 2016, 79(1): 59–75. link1
[37] Massri N E, Lemgruber A P, Rowe I J, et al. Photobiomodulationinduced changes in a monkey model of Parkinson’s disease: Changes in tyrosine hydroxylase cells and GDNF expression in the striatum [J]. Experimental Brain Research, 2017, 235(6): 1861–1874. link1
[38] Johnstone D M, El Massri N, Moro C, et al. Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism—An abscopal neuroprotective effect [J]. Neuroscience, 2014, 274: 93–101. link1
[39] Kim B, Mitrofanis J, Stone J, et al. Remote tissue conditioning is neuroprotective against MPTP insult in mice [J]. Ibro Reports, 2018, 4: 14–17. link1
[40] Ganeshan V, Skladnev N V, Kim J Y, et al. Pre-conditioning with remote photobiomodulation modulates the brain transcriptome and protects against MPTP insult in mice [J]. Neuroscience, 2019, 400: 85–97. link1
[41] Santos L, Olmo-Aguado S D, Valenzuela P L, et al. Photobiomodulation in Parkinson’s disease: A randomized controlled trial [J]. Brain Stimulation, 2019, 12(3): 810. link1
[42] Willis G L, Boda J, Freelance C B. Polychromatic light exposure as a therapeutic in the treatment and management of Parkinson’s disease: A controlled exploratory trial [J]. Frontiers in Neurology, 2018, 9: 741. link1
[43] Paus S, Schmitz-Hübsch T, Wüllner U, et al. Bright light therapy in Parkinson’s disease: A pilot study [J]. Movement Disorders: Official Journal of the Movement Disorder Society, 2007, 22(10): 1495–1498. link1
[44] Videnovic A, Klerman E B, Wang W, et al. Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: A randomized clinical trial [J]. Jama Neurology, 2017, 74(4): 411–418. link1
[45] Rutten S, Vriend C, Smit J H, et al. Bright light therapy for depression in Parkinson disease: A randomized controlled trial [J]. Neurology, 2019, 92(11): e1145–e1156. link1
[46] Gonzalez-Lima F, Barrett D W. Augmentation of cognitive brain functions with transcranial lasers [J]. Frontiers in Systems Neuroscience, 2014, 8: 36. link1
[47] Barrett D W, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans [J]. Neuroscience, 2013, 230: 13–23. link1
[48] Jahan A, Nazari M A, Mahmoudi J, et al. Transcranial near-infrared photobiomodulation could modulate brain electrophysiological features and attentional performance in healthy young adults [J]. Lasers in Medical Science, 2019, 34(6): 1193–1200. link1
[49] Song P, Han T, Lin H, et al. Transcranial near-infrared stimulation may increase cortical excitability recorded in humans [J]. Brain Research Bulletin, 2020, 155: 155–158. link1
[50] Hart N S, Fitzgerald M. A new perspective on delivery of rednear-infrared light therapy for disorders of the brain [J]. Discovery Medicine, 2016, 22(120): 147–156. link1
京公网安备 11010502051620号
